For: | Xu HB, Gong YP, Cheng J, Chu YW, Xiong SD. CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue. World J Gastroenterol 2005; 11(32): 4979-4985 [PMID: 16124049 DOI: 10.3748/wjg.v11.i32.4979] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i32/4979.htm |
Number | Citing Articles |
1 |
A. J. Czaja. Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets. Alimentary Pharmacology & Therapeutics 2014; 40(3): 261 doi: 10.1111/apt.12825
|
2 |
Daniel A. Patten, Shishir Shetty. More Than Just a Removal Service: Scavenger Receptors in Leukocyte Trafficking. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02904
|
3 |
Merav Darash-Yahana, John W. Gillespie, Stephen M. Hewitt, Yun-Yun K. Chen, Shin Maeda, Ilan Stein, Satya P. Singh, Roble B. Bedolla, Amnon Peled, Dean A. Troyer, Eli Pikarsky, Michael Karin, Joshua M. Farber, Derya Unutmaz. The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers. PLoS ONE 2009; 4(8): e6695 doi: 10.1371/journal.pone.0006695
|
4 |
Albert J. Czaja. Transitioning from Idiopathic to Explainable Autoimmune Hepatitis. Digestive Diseases and Sciences 2015; 60(10): 2881 doi: 10.1007/s10620-015-3708-7
|
5 |
Daniel A. Patten, Alex L. Wilkinson, Ayla O'Keeffe, Shishir Shetty. Scavenger Receptors: Novel Roles in the Pathogenesis of Liver Inflammation and Cancer. Seminars in Liver Disease 2022; 42(01): 061 doi: 10.1055/s-0041-1733876
|
6 |
Ibrahim G. Saleh, Zulfiqar Ali, Naohito Abe, Farid M. Hamada, Mohamed F. Abd-Ellah, Larry A. Walker, Ikhlas A. Khan, Mohammad K. Ashfaq. Possible hepatocellular toxicity of EGCG under the influence of an inflammagen. Journal of Applied Biomedicine 2014; 12(4): 291 doi: 10.1016/j.jab.2014.03.001
|
7 |
Heidrun Ellinger-Ziegelbauer, Melanie Adler, Alexander Amberg, Arnd Brandenburg, John J. Callanan, Susan Connor, Michael Fountoulakis, Hans Gmuender, Albrecht Gruhler, Philip Hewitt, Mark Hodson, Katja A. Matheis, Diane McCarthy, Marian Raschke, Björn Riefke, Christina S. Schmitt, Max Sieber, Alexandra Sposny, Laura Suter, Brian Sweatman, Angela Mally. The enhanced value of combining conventional and “omics” analyses in early assessment of drug-induced hepatobiliary injury. Toxicology and Applied Pharmacology 2011; 252(2): 97 doi: 10.1016/j.taap.2010.09.022
|
8 |
Xiaofeng Jiang, Wenyu Sun, Lei Zhu, Dawei Guo, Honglei Jiang, Dongyan Ma, Junzhe Jin, Yu Zhao, Jian Liang. Expression of CXCR6 on CD8+ T cells was up-regulated in allograft rejection. Transplant Immunology 2010; 22(3-4): 179 doi: 10.1016/j.trim.2009.12.001
|
9 |
Rita Pombinho, Sandra Sousa, Didier Cabanes. Scavenger Receptors: Promiscuous Players during Microbial Pathogenesis. Critical Reviews in Microbiology 2018; 44(6): 685 doi: 10.1080/1040841X.2018.1493716
|
10 |
Alexander Wehr, Christer Baeck, Felix Heymann, Patricia Maria Niemietz, Linda Hammerich, Christian Martin, Henning W. Zimmermann, Oliver Pack, Nikolaus Gassler, Kanishka Hittatiya, Andreas Ludwig, Tom Luedde, Christian Trautwein, Frank Tacke. Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis. The Journal of Immunology 2013; 190(10): 5226 doi: 10.4049/jimmunol.1202909
|
11 |
Jan Korbecki, Karolina Bajdak-Rusinek, Patrycja Kupnicka, Patrycja Kapczuk, Donata Simińska, Dariusz Chlubek, Irena Baranowska-Bosiacka. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. International Journal of Molecular Sciences 2021; 22(7): 3490 doi: 10.3390/ijms22073490
|
12 |
Bin Hu, Jiamin Wang, Ning Zhao, Shengyong Feng, Rashidin Abdugheni, Gaojian Li, Wei Liu, Sichao Gao, Xing An, Shuyi Han, Hongxuan He. Regulatory mechanisms of Capillaria hepatica infection on Brandt's Vole (Lasiopodomys brandtii) population. Ecotoxicology and Environmental Safety 2024; 284: 116849 doi: 10.1016/j.ecoenv.2024.116849
|
13 |
Sulemon Chaudhry, Jean Emond, Adam Griesemer. Immune Cell Trafficking to the Liver. Transplantation 2019; 103(7): 1323 doi: 10.1097/TP.0000000000002690
|
14 |
Kexin JIA, Zhi MA, Yinhao ZHANG, Kaihong XIE, Jianan LI, Jianzhi WU, Jiaorong QU, Fanghong LI, Xiaojiaoyang LI. Picroside II promotes HSC apoptosis and inhibits the cholestatic liver fibrosis in Mdr2−/− mice by polarizing M1 macrophages and balancing immune responses. Chinese Journal of Natural Medicines 2024; 22(7): 582 doi: 10.1016/S1875-5364(24)60571-6
|
15 |
IG Saleh, Z Ali, MA Hammad, FD Wilson, FM Hamada, MF Abd-Ellah, LA Walker, IA Khan, MK Ashfaq. Stem cell intervention ameliorates epigallocatechin-3-gallate/lipopolysaccharide-induced hepatotoxicity in mice. Human & Experimental Toxicology 2015; 34(11): 1180 doi: 10.1177/0960327115572707
|
16 |
Yanli Liu, Rong Liu, Cheng Zhen, Quanfang Guo, Liping Wu, Zhaoxi Ding, Yushun Bi, Zhiyu Liu. Experimental study on the efficacy of Fuganling granula on protecting against immunological hepatic injury. Frontiers of Medicine in China 2009; 3(1): 91 doi: 10.1007/s11684-009-0011-z
|
17 |
Anette Brass, Erwin Brenndörfer. The Role of Chemokines in Hepatitis C Virus-Mediated Liver Disease. International Journal of Molecular Sciences 2014; 15(3): 4747 doi: 10.3390/ijms15034747
|
18 |
Ivica Grgurevic, Tonci Bozin, Mislav Mikus, Michal Kukla, James O’Beirne. Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach. Cancers 2021; 13(22): 5844 doi: 10.3390/cancers13225844
|
19 |
Ling Tang, Xiao Yu, Lu Zou, Shaobin Li, Yanqi Cheng, Yuqin Wu, Lianjun Xing, Hong Fang, Rajeev K. Singla. Qinggan Huoxue Recipe Protects against Experimental Alcoholic Liver Fibrosis through CXCL16 Inhibition. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/5642713
|
20 |
Alexander Wehr, Christer Baeck, Florian Ulmer, Nikolaus Gassler, Kanishka Hittatiya, Tom Luedde, Ulf Peter Neumann, Christian Trautwein, Frank Tacke, Anna Alisi. Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury. PLoS ONE 2014; 9(11): e112327 doi: 10.1371/journal.pone.0112327
|
21 |
Alexander Wehr, Frank Tacke. The Roles of CXCL16 and CXCR6 in Liver Inflammation and Fibrosis. Current Pathobiology Reports 2015; 3(4): 283 doi: 10.1007/s40139-015-0090-2
|
22 |
Michael N. VanSaun, Alisha M. Mendonsa, D. Lee Gorden, Gianluigi Giannelli. Hepatocellular Proliferation Correlates with Inflammatory Cell and Cytokine Changes in a Murine Model of Nonalchoholic Fatty Liver Disease. PLoS ONE 2013; 8(9): e73054 doi: 10.1371/journal.pone.0073054
|
23 |
Saisai Zhang, Wei Zhang, Lihua Shi, Anqi Xie, Yihui Shao, Yanna Ye, Xuebo Pan, Zhuofeng Lin, Xiaokun Li, Yi Zhang. Hepatic CXCL16 is increased in gallstone accompanied with liver injury. European Journal of Clinical Investigation 2017; 47(9): 667 doi: 10.1111/eci.12788
|